in all of these trials , as well as in the report of van nagell et al ( cancer 57:1451-1454 , 1986 ) of adjuvant vincristine , actinomycin-d , and cyclophosphamide ( vac ) chemotherapy , there are too few patients to make any formal statistical comparison of the groups , although the surgery plus cyvadic group appears to be the most promising .
C0042679
vincristine
C0057010
cyvadic